As we mentioned above, literature reviews suggested the relationship between p53 and these markers, and possibly control cellular processes through the interaction with wild type or mutant p53 involved in inflammatory regulation in CS-CCA development. This evidence concerns the gene TP53 and cholangiocarcinoma.